Lew is an accomplished regulatory leader with more than 30 years of experience in the pharmaceutical industry. Lew has led teams at Allergan, Johnson & Johnson, as well as biotechs such as Acadia and Quark. He has extensive global expertise with small molecule and biologic development. He has been involved in all stages of development from pre-IND/pre-CTA through Phase 1,2,3 development, NDA, MAA, NDS submission and approval and support of marketed products. Lew led the teams responsible for global approvals of OZURDEX, ACUVAIL ZYMAXID, LUMIGAN, COMBIGAN and ALPHAGAN. Lew holds degrees from University of Colorado (Ph.D.), Fairleigh Dickinson University (MBA), Philadelphia College of Pharmacy and Science (B.S.), as well as many industry designations.